Status:
UNKNOWN
Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.
Lead Sponsor:
Ankara University
Conditions:
Allergen Immunotherapy, Immunological Mechanisms,Monosensitized,Polysensitized,Clinical Efficacy
Eligibility:
All Genders
18-50 years
Brief Summary
The incidence of allergic rhinitis and asthma is increasing in throughout the world as well as our country. Allergen-specific immunotherapy has been in use for almost 100 years. Since then, it is reco...
Eligibility Criteria
Inclusion
- Patients with moderate or persistent allergic rhinitis with or without mild asthma are selected in the study. They have to sensitized to only house dust mites or at least 2 different allergens including house dust mites.
- \-
Exclusion
- The presence of severe asthma, previously received allergen immunotherapy and other contraindications of allergen specific immunotherapy.
- \-
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01795846
Start Date
March 1 2013
End Date
March 1 2014
Last Update
March 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University, Faculty of Medicine
Ankara, Turkey (Türkiye), 06100